1 min read|45 words
Researchers are improving how Premenstrual Dysphoric Disorder (PMDD) is diagnosed, working to standardize clinical criteria and reduce diagnostic delays. Better diagnostic frameworks could enable faster access to treatment for the 3–8% of menstruating individuals affected by this severe condition.
Read the full article on GMJ Newsroom →
Was this article helpful?

